Agency Information Collection Activities; Biological Materials Deposit
Summary
The Patent and Trademark Office has submitted an information collection request concerning the deposit of biological materials for review and approval by the Office of Management and Budget. A public comment period is open until April 8, 2026.
What changed
The Patent and Trademark Office (PTO) has submitted a request to the Office of Management and Budget (OMB) for review and approval of an information collection activity related to the deposit of biological materials. This submission initiates a public comment period, allowing interested parties to provide feedback on the proposed collection.
Regulated entities, particularly those in the pharmaceutical and biotechnology sectors, should review the proposed information collection requirements and submit comments by April 8, 2026, if they have concerns or suggestions. Failure to comment may result in the approved collection not reflecting industry needs or operational realities.
What to do next
- Review the proposed information collection requirements for biological materials deposit.
- Submit comments to OMB by April 8, 2026, if applicable.
Source document (simplified)
Legal Status This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Legal Status
Notice
Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Deposit of Biological Materials
A Notice by the Patent and Trademark Office on 03/09/2026
- 1.
1.
This document has a comment period that ends in 25 days.
(04/08/2026) Submit a public comment
Thank you for taking the time to create a comment. Your input is important.
Once you have filled in the required fields below you can preview and/or submit your comment to the Commerce Department for review. All comments are considered public and will be posted online once the Commerce Department has reviewed them.
You can view alternative ways to comment or you may also comment via Regulations.gov at https://www.regulations.gov/commenton/PTO-P-2025-0446-0002.
It appears that you have attempted to comment on this document before
so we've restored your progress.
Start over.
1.
2. Comment * What is your comment about? Upload File(s) Note: You can attach your comment as a file and/or attach supporting
documents to your comment. Attachment Requirements.
Email this will NOT be posted on regulations.gov
Opt to receive email confirmation of submission and tracking number? Tell us about yourself! I am... * An Individual An Organization Anonymous First Name * Last Name * City Region State Alabama Alaska American Samoa Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming Zip Country Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Côte d'Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia, the Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Viet Nam Virgin Islands, British Virgin Islands, U.S. Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Phone Organization Type * Company Organization Federal State Local Tribal Regional Foreign U.S. House of Representatives U.S. Senate Organization Name * You are filing a document into an official docket. Any personal
information included in your comment text and/or uploaded
attachment(s) may be publicly viewable on the web. I read and understand the statement above.
- Preview Comment Please review the Regulations.gov privacy notice and user notice.
- Document Details Published Content - Document Details Agencies Department of Commerce Patent and Trademark Office Document Citation 91 FR 11292 Document Number 2026-04519 Document Type Notice Pages 11292-11293 (2 pages) Publication Date 03/09/2026 Published Content - Document Details
- PDF Official Content
- View printed version (PDF) Official Content
- Document Details Published Content - Document Details Agencies Department of Commerce Patent and Trademark Office Document Citation 91 FR 11292 Document Number 2026-04519 Document Type Notice Pages 11292-11293 (2 pages) Publication Date 03/09/2026 Published Content - Document Details
- Document Dates Published Content - Document Dates Comments Close 04/08/2026 Dates Text To ensure consideration, you must submit comments regarding this information collection on or before April 8, 2026. Published Content - Document Dates
Table of Contents Enhanced Content - Table of Contents This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.- AGENCY:
- ACTION:
- SUMMARY:
- DATES:
- ADDRESSES:
- FOR FURTHER INFORMATION CONTACT:
- SUPPLEMENTARY INFORMATION:
- A. Deposits of Biological Materials
- B. Request for Depository Approval Enhanced Content - Table of Contents
Public Comments Enhanced Content - Public Comments Comments are being accepted - Submit a public comment.
Enhanced Content - Public Comments
- Regulations.gov Data Enhanced Content - Regulations.gov Data
FederalRegister.gov retrieves relevant information about this document
from Regulations.gov to provide users with additional context. This
information is not part of the official Federal Register document.
0651-0022 Deposit of Biological Materials
Comment Due Date 04/08/2026 Docket ID PTO-P-2025-0446 Supporting Documents No supporting documents available Enhanced Content - Regulations.gov Data
- Sharing Enhanced Content - Sharing Shorter Document URL https://www.federalregister.gov/d/2026-04519 Email Email this document to a friend Enhanced Content - Sharing
- Print Enhanced Content - Print
- Print this document Enhanced Content - Print
- Document Statistics Enhanced Content - Document Statistics Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Page views 62
as of
03/14/2026 at 2:15 pm EDT Enhanced Content - Document Statistics
- Other Formats Enhanced Content - Other Formats This document is also available in the following formats:
JSON Normalized attributes and metadata XML Original full text XML MODS Government Publishing Office metadata More information and documentation can be found in our developer tools pages.
Enhanced Content - Other Formats
- Public Inspection Public Inspection This PDF is FR Doc. 2026-04519 as it appeared on Public Inspection on
03/06/2026 at 8:45 am.
It was viewed
8
times while on Public Inspection.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507. Learn more here.
Public Inspection
Published Document: 2026-04519 (91 FR 11292) This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Document Headings Document headings vary by document type but may contain
the following:
- the agency or agencies that issued and signed a document
- the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
- the agency docket number / agency internal file number
- the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details.
Department of Commerce
Patent and Trademark Office
AGENCY:
United States Patent and Trademark Office, Department of Commerce.
ACTION:
Notice of information collection; request for comments.
SUMMARY:
The United States Patent and Trademark Office (USPTO) will submit the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995, on or after the date of publication of this notice. The USPTO invites comments on the information collection renewal of 0651-0022, which helps the USPTO assess the impact of its information collection requirements and minimize the reporting burden to the public. Public comments were previously requested via the Federal Register on November 19, 2025 during a 60-day comment period (90 FR 52038). This notice allows for an additional 30 days for public comments.
DATES:
To ensure consideration, you must submit comments regarding this information collection on or before April 8, 2026.
ADDRESSES:
Written comments and recommendations for this information collection should be submitted within 30 days of the publication of this notice on the following website, http://www.reginfo.gov/public/do/PRAMain. You may find this particular information collection by selecting “Currently under 30-day Review-Open for Public Comments” or by using the search function and entering either the title of the information collection or the OMB Control Number, 0651-0022. Do not submit Confidential Business Information or otherwise sensitive or protected information.
FOR FURTHER INFORMATION CONTACT:
- This information collection request may be viewed at http://www.reginfo.gov. Follow the instructions to view the Department of Commerce, USPTO information collections currently under review by OMB.
- Email: InformationCollection@uspto.gov. Include “0651-0022 information request” in the subject line of the message.
- Mail: Justin Isaac, Office of the Chief Administrative Officer, United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450.
- Telephone: Raul Tamayo, Senior Legal Advisor, 571-272-7728.
SUPPLEMENTARY INFORMATION:
Title: Deposit of Biological Materials.
OMB Control Number: 0651-0022.
Abstract: This information collection covers information from patent applicants who seek to deposit biological material in connection with a patent application according to 37 CFR 1.801-1.809. The information collected from such patent applicants consists of information and documentation demonstrating the applicant's compliance with regulatory requirements, as well as information regarding the biological sample after it is deposited. This collection also covers communications from institutions that wish to be recognized by the USPTO as a suitable depository to receive deposits for patent application purposes. The information collection requirements for these actions are separate, as discussed below.
A. Deposits of Biological Materials
The deposit of biological material as part of a patent application is authorized by 35 U.S.C. 2(b)(2) and 112. The term “biological material” is defined in 37 CFR 1.801 as including material that is capable of self-replication, either directly or indirectly. When an invention involves a biological material, words and figures may not sufficiently describe how to make and use the invention in a reproducible material as required by 35 U.S.C. 112. In such cases, the inventive biological material must be known and readily available to the public or can be made or isolated without undue experimentation (see 37 CFR 1.802). In order to satisfy the “known and readily available” requirement, the biological material may be deposited in a suitable depository that has been recognized as an International Depository Authority (IDA) established under the Budapest Treaty per 37 CFR 1.803(a)(1), or any other depository recognized to be suitable by the USPTO per 37 CFR 1.803(a)(2). Under the authority of 35 U.S.C. 2(b)(2), the deposit rules (37 CFR 1.801-1.809) set forth examination procedures and conditions of deposit which must be satisfied in the event a deposit is required.
In cases where a deposit of biological material that is capable of self-replication either directly or indirectly is made, and the deposit is not made under the Budapest Treaty, the USPTO collects information to determine whether the deposit meets the viability requirements of 37 CFR 1.807. This information includes a viability statement under 37 CFR 1.807, such statement identifying:
(1) The name and address of the depository where the deposit was made;
(2) The name and address of the depositor;
(3) The date of the deposit;
(4) The identity of the deposit and the accession number given by the depository;
(5) The date of the viability test;
(6) The procedure used to obtain a sample if the test was not done by the depository; and
(7) A statement that the deposit is capable of reproduction.
A viability statement is not required when a deposit is made and accepted under the Budapest Treaty.
This information collection also covers additional information that may be gathered by the USPTO after a biological material is deposited into the recognized depository. For example, depositors may be required to submit verification statements for biological material deposited after the effective filing date of a patent application, or written notification that an acceptable deposit will be made. Occasionally a deposit may be lost, contaminated, or is not able to self-replicate, and a replacement or supplemental deposit needs to be made. This information collection includes a required written notification that the depositor must submit to the USPTO disclosing the particulars of such situation and, in the case of an issued patent, requesting a certificate of correction.
There are no forms associated with the information collected by the USPTO in connection with the deposit of biological material. However, there are forms available under the Budapest Treat for use with international depositories. ( printed page 11293)
B. Request for Depository Approval
Institutions that wish to be recognized by the USPTO as a suitable depository to receive deposits for patent purposes are required by 37 CFR 1.803(b) to make a request demonstrating that they are qualified to store and test the biological material submitted to them under patent applications (see also MPEP 2405). This information collection covers the information that a depository must submit to the USPTO when seeking recognition by the USPTO as a suitable depository under 37 CFR 1.803(a)(2). This information enables the USPTO to evaluate whether such a depository has internal practices (both technical and administrative) and the technical ability sufficient to protect the integrity of the biological material being stored by U.S. patent applicants and patent owners. This information includes:
(1) The name and address of the depository seeking recognition under 37 CFR 1.803(a)(2),
(2) Detailed information as to the capacity of the depository to comply with the requirements of 37 CFR 1.803(a)(2), including information on its legal status, scientific standing, staff, and facilities;
(3) An indication that the depository intends to be available, for the purposes of deposit, to any depositor under these same conditions;
(4) Where the depository intends to accept for only certain kinds of biological material, specify such kinds; and
(5) An indication of the amount of any fees that the depository will, upon acquiring the status of suitable depository under paragraph (a)(2) of this section, charge for storage, viability statements and furnishings of the samples of the deposit.
This collection also includes additional information gathered by the USPTO that may be needed after a depository has been recognized by the USPTO under 37 CFR 1.803(a)(2), such as requests to handle additional types of biological material other than the material originally recognized, and viability statements that depositories may submit on behalf of depositors for deposits tested at the depository and/or documentation proving the public has been notified where to obtain samples. There are no forms associated with requests under 37 CFR 1.803(b) to become a recognized depository.
Forms:
- BP/1 (Statement in the Case of an Original Deposit (Rule 6.1))
- BP/2 (Statement in the Case of a New Deposit with the Same International Depository Authority (Rule 6.2))
- BP/3 (Statement in the Case of a New Deposit with Another International Depository Authority (Rule 6.2))
- BP/9 (Viability Statement (Rule 10.2) (International Form)) Type of Review: Extension and revision of a currently approved information collection.
Affected Public: Private sector.
Respondent's Obligation: Required to obtain or retain benefits.
Frequency: On occasion.
Estimated Number of Annual Respondents: 1,501 respondents.
Estimated Number of Annual Responses: 1,501 responses.
Estimated Time per Response: The USPTO estimates that the responses in this information collection will take the public approximately 1 to 5 hours to complete, depending on the complexity of the situation. This includes the time to gather the necessary information, create the document, and submit the completed item to the USPTO.
Estimated Total Annual Respondent Burden Hours: 1,505 hours.
Estimated Total Annual Respondent Non-hourly Cost Burden: $4,306,511.
Justin Isaac,
Information Collections Officer, Office of the Chief Administrative Officer, United States Patent and Trademark Office.
[FR Doc. 2026-04519 Filed 3-6-26; 8:45 am]
BILLING CODE 3510-16-P
Published Document: 2026-04519 (91 FR 11292)
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Trade Regulation alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FR: Patent and Trademark Office publishes new changes.